Table 1.
N | % | ||
---|---|---|---|
Pre-Existing Conditions | |||
Chronic lung disease (n = 919) |
existing | 132 | 14.4% |
Mental disorders (n = 914) | existing | 125 | 13.7% |
Chronic pain (n = 912) | existing | 46 | 5.0% |
Coronary artery disease (n = 912) |
existing | 49 | 5.1% |
Chronic heart failure (n = 913) | existing | 40 | 4.2% |
Coagulation disorder (n = 913) | existing | 27 | 3.0% |
Acute medical treatment | |||
Inpatient treatment (n = 952) | no | 711 | 75.8% |
yes | 148 | 15.5% | |
yes, with ICU | 82 | 8.6% | |
Duration since infection at the time points of presentation | |||
Duration since infection (1st presentation) |
3–6 Mon | 249 | 26.2% |
6–9 Mon | 250 | 26.3% | |
9–12 Mon | 178 | 18.7% | |
12–15 Mon | 149 | 15.7% | |
15–18 Mon | 81 | 8.5% | |
18–24 Mon | 42 | 4.4% | |
>24 Mon | 3 | 0.3% | |
Duration since infection (1st re-presentation) |
3–6 Mon | 1 | 0.3% |
6–9 Mon | 67 | 17.7% | |
9–12 Mon | 97 | 25.6% | |
12–15 Mon | 99 | 26.1% | |
15–18 Mon | 66 | 17.4% | |
18–24 Mon | 46 | 12.1% | |
>24 Mon | 3 | 0.8% | |
Duration since infection (2nd re-presentation) |
3–6 Mon | 0 | 0.0% |
6–9 Mon | 0 | 0.0% | |
9–12 Mon | 8 | 6.2% | |
12–15 Mon | 39 | 30.2% | |
15–18 Mon | 40 | 31.0% | |
18–24 Mon | 33 | 25.6% | |
>24 Mon | 9 | 7.0% |